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ABSTRACT
SIP1/ZEB2 is a member of the dEF-1 family of two-
handed zinc finger nuclear factors. The expression
of these transcription factors is associated with
epithelial mesenchymal transitions (EMT) during
development. SIP1 is also expressed in some breast
cancer cell lines and was detected in intestinal
gastric carcinomas, where its expression is inversely
correlated with that of E-cadherin. Here, we show
that expression of SIP1 in human epithelial cells
results in a clear morphological change from an
epithelial to a mesenchymal phenotype. Induction
of this epithelial dedifferentiation was accompanied
by repression of several cell junctional proteins, with
concomitant repression of their mRNA levels.
Besides E-cadherin, other genes coding for crucial
proteins of tight junctions, desmosomes and gap
junctions were found to be transcriptionally regulated
by the transcriptional repressor SIP1. Moreover,
study of the promoter regions of selected genes by
luciferase reporter assays and chromatin immuno-
precipitation shows that repression is directly medi-
atedbySIP1.Thesedataindicatethat,duringepithelial
dedifferentiation, SIP1 represses in a coordinated
manner the transcription of genes coding for junc-
tional proteins contributing to the dedifferentiated
state; this repression occurs by a general mechanism
mediated by Smad Interacting Protein 1 (SIP1)-
binding sites.
INTRODUCTION
Smad Interacting Protein 1 (SIP1; also known as ZEB2, for
zinc finger E-box-binding protein 2 and ZFHX1B) belongs to
the dEF-1 or ZEB protein family. These proteins are charac-
terized by a homeodomain flanked by two separated, highly
conserved zinc finger clusters: an N-terminal and a C-terminal
one, which contain four and three zinc fingers, respectively
(1). Each zinc finger cluster can bind independently to
CACCT(G) sequences present in promoter regions of genes
involved in differentiation and development, such as the
Xenopus Xbra2 promoter, the human a4-integrin promoter
and the E-cadherin promoter (2). The integrity of the two
zinc finger clusters of SIP1 is necessary for its binding as a
monomer to the target promoter sequences (2). SIP1 acts as a
transcriptional repressor and contains consensus binding sites
for the corepressor CtBP (3,4). Gene repression by SIP1 has
been reported to occur both dependent on and independent of a
CtBP corepressor complex (4,5). Recently it was reported that
the SIP1 protein can be sumoylated, which attenuates gene
repression by disruption of CtBP recruitment (6).
We reported previously that binding of the E-cadherin pro-
moter by SIP1 downregulates E-cadherin expression (7). In
epithelial MDCK cells, this suppression of E-cadherin expres-
sion was accompanied by loss of aggregation and acquisition
of invasive properties. An inverse correlation between SIP1
and E-cadherin expression levels was observed in several epi-
thelial tumor cell lines, such as MDA-MB-435S1 and MDA-
MB-231; high levels of SIP1 mRNA are observed in these
cells while E-cadherin transcripts are not detectable. Vice
versa, a transformed breast cancer cell line, MCF7/AZ, still
expresses E-cadherin but lacks SIP1 expression (7). In the
intestinal type of gastric carcinomas, the downregulation of
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E-cadherin expression was again shown to be inversely
correlated with SIP1 mRNA expression levels (8). SIP1 was
also identified in a large-scale screen for cancer related genes,
which demonstrates its putative role in oncogenic transforma-
tion (9). Inaddition,SIP1 expression is involved inneurogenesis
of Xenopus laevis (10,11). SIP1 deletions as well as nonsense
and frameshift mutations were demonstrated to play a role in
Hirschsprung disease, a syndrome characterized by mental
retardation and multiple congenital anomalies (12–15).
In the adherens junction, E-cadherin complexes contain
several catenins, through which E-cadherin is linked to the
actin cytoskeleton. Intercellular interactions between the
E-cadherin proteins on adjacent cells result in strong cell–
cell adhesion and explicit epithelial cell polarity. Abnormal-
ities in epithelial cells are at the root of the majority of human
cancers. In these cells, E-cadherin fulfills the role of a major
cell–cell adhesion molecule and potently suppresses invasion.
Epithelial mesenchymal transition (EMT) occurs in patholo-
gical situations, such as wound healing, fibrosis and the
acquisition of an invasive phenotype in epithelial tumors
(16). This EMT allows cells to dissociate from epithelial tissue
and become more motile. Furthermore, EMT also participates
in mesoderm and neural crest formation during normal devel-
opment. The putative role of SIP1 in EMT processes was
suggested by the phenotype of the Zfhx1b-knock-out mouse,
which displays delamination arrest of cranial neural crest cells
resulting in the loss of migratory behavior of these cells (17).
This delamination is normally mediated by the triggering of
EMT (16), indicating that SIP1 is a key player in EMT pro-
cesses during development. The adherens junctions are not the
only cell–cell junctions nullified during EMT processes. For
tight junctions, which are adjacent to the adherens junctions, it
was recently shown that the transcriptional repressor Snail
directly represses claudin and occludin expression, and
induces EMT concomitantly with the disappearance of tight
junctions (18,19). Disappearance of the desmosome, another
cell junction complex, was also reported in several EMT
events (19,20).
It is unlikely that E-cadherin is the only SIP1 target gene
that is involved in the triggering of SIP1-induced conversion
of epithelial cells to a more fibroblast-like morphology. Using
human epithelial cell lines with conditional SIP1 expression,
we examined the molecular mechanism involved in the SIP1-
induced EMT-like process. This study revealed that SIP1
expression downregulates several cell junctional genes.
Furthermore, we illustrate that this downregulation is caused
by SIP1-induced repression of promoter activity. Our results
demonstrate that by binding promoter regions containing
SIP1 recognition sites, SIP1 performs its role in EMT-like
processes by altering in a coordinated fashion the functionality
of adherens junctions, tight junctions, desmosomes and gap
junctions.
MATERIALS AND METHODS
Cell culture and transfection
The colon cancer cell line DLD1 was provided with the
T-REX system (Invitrogen) by Van de Wetering et al. (21)
to yield DLD1Tr21 Tet-on cells. This Tet-on system activates
transcription of the gene of interest in the presence of
doxycycline (Dox). The cells were cultured in RPMI with 10%
fetal calf serum (FCS), 100 U/ml penicillin and 100 mg/ml
streptomycin. The cDNAs for wild-type SIP1 and for mutant
SIP1 (mutated in both zinc finger clusters) (1) were cloned in
the pcDNA4/TO vector (Invitrogen). To this end, the wild-
type and mutant SIP1 fragments (1), both of which contain an
N-terminal myc-tag, were cut from the pCS3 vectors, using
XbaI and ClaI, and blunted. Fragments were cloned into the
EcoRV digested pcDNA4/TO vector. Both constructs were
stably transfected in DLD1Tr21 cells by electroporation
using 30 mg of the SIP1 expression plasmid. Transfectants
were selected in 500 mg/ml Zeocin (Invitrogen) and 10 mg/ml
blasticidin (Invitrogen) for 2 weeks. Clones were isolated
using cloning cylinders and designated DLD1Tr21/WTSIP1
and DLD1Tr21/mutSIP1. SIP1 expression was induced using
Dox (2 mg/ml, Sigma). As the transfected vectors encode
myc-tagged SIP1 fusion proteins, resistant colonies were
tested for induction of SIP1 expression by immunofluorescent
staining with the anti-myc antibody 9E10 (22). A squamous
epidermoid carcinoma cell line A431 with Tet-on Dox-
regulated SIP1 expression was constructed (J. Mejlvang et al.,
manuscript submitted). These cells, designated A431/WTSIP1
were cultured in DMEM with 10% FCS, 100 mg/ml penicillin
and 100 mg/ml streptomycin.
SDS–PAGE and immunoblotting
Cells were rinsed with phosphate-buffered saline (PBS) and
proteins were extracted with 1· Laemmli lysis buffer. Total
protein lysates of cultured cells were loaded on an 8% one-
dimensional SDS–PAGE gel and the separated proteins were
transferred on to Immobilon-P membranes (Millipore Corp.).
After blocking with 5% non-fat dry milk in Tris buffered saline
(TBS, pH 7.4) containing 0.01% Tween-20, the membranes
were incubated with primary antibody. After several washing
steps in TBS, the membranes were incubated with secondary
horseradish peroxidase (HRP)-conjugated antibodies (dilution
1:3000; Amersham Pharmacia Biotech). Proteins were detec-
ted using the enhanced chemiluminescence (ECL) detection
system (Amersham Pharmacia Biotech).
Antibodies and immunofluorescence
Fixation and immunofluorescence were performed following
standard procedures (23). Primary antibodies used for both
immunofluorescence and immunoblotting were mouse mono-
clonal antibody HECD1, raised against human E-cadherin
(1:75; Takara), polyclonal anti-aE-catenin antibody (1:500;
Sigma), polyclonal anti-b-catenin antibody (1:1000; Sigma),
mouse anti-myc antibody 9E10 [1:500; (22)], rabbit anti-myc
antibody (1:100; Upstate), mouse anti-p120ctn antibody
pp120 (1:200; Transduction) and mouse anti-N-cadherin anti-
body (1:1000; Transduction). Mouse anti-plakophilin 2 anti-
body (1:10; Progen), mouse anti-desmoplakin I + II antibody
(1:10; Boehringer Mannheim) and mouse anti-claudin 4 anti-
body (1:300; Zymed) were used for immunofluorescence only.
A specific monoclonal antibody for SIP1 was generated
by immunizing C57/BL6 mice with a fusion protein composed
of glutathione S-transferase (GST) coupled to mouse SIP1
amino acids 26–129, according to a described protocol (24).
After characterization of the antibody, supernatant from
hybridoma 7F7 was purified on a protein-G Sepharose column
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(Amersham Pharmacia Biotech, Rainham, UK). Secondary
antibodies were Alexa-488 and Alexa-594 coupled anti-
mouse, anti-rat or anti-rabbit Ig (1:500; Molecular Probes).
Real-time quantitative RT–PCR (Q-RT–PCR)
Primers and probes used for amplification were designed
using Primer Express 1.0 software (Perkin-Elmer Applied
Biosystems). cDNA synthesis and PCR amplification were
described previously (25). The average threshold cycle of
triplicate reactions was used for all subsequent calculations
using the delta Ct method. Sequences of primers for mouse
SIP1 cDNA amplification were: 50-AGGCATATGGTGACG-
CACAA-30 and 50-CTTGAACTTGCGGTTACCTGC-30. The
Taqman probe sequence was: 50-FAM-CAGATCAGCAC-
CAAATGCTAACCCAAGG-TAMRA-30 (Eurogentec). For
human E-cadherin, the primers were: 50-GTCACTGACAC-
CAACGATAATCCT-30 and 50-TTTCAGTGTGGTGATTA-
CGACGTTA-30. The E-cadherin Taqman probe sequence
was: 50-FAM-TTCAATCCCACCACGTACAAGGGTCAG-
TAMRA-30. For human N-cadherin, the primers were:
50-AGCCTGACACTGTGGAGCCT-30 and 50-TCAGCGTG-
GATGGGTCTTTC-30 and the Taqman probe sequence was:
50-FAM-ATGCCATCAAGCCTGTGGGAATCCG-TAMRA-
30. For human claudin 4, the primers were: 50-GGCCGG-
CCTTATGGTGATA-30 and 50-GCCACCAGCGGATTGTA-
GA-30; for human tight junction protein 3 (ZO-3), the primers
were: 50-CGTCGCCTCTACGCACAAG-30 and 50-TGAAG-
AGGTGGCTGCTGTGTT-30; for human P-cadherin (CDH3),
the primers were: 50-ATGACGTGGCACCAACCAT-30 and
50-GTTAGCCGCCTTCAGGTTCTC-30; for human plako-
philin 2 (PKP2), the primers were: 50-CGGAAATCTTCACC-
GAACCA-30 and 50-AACGGCCTCCAACAAAATCAT-30;
for human desmoplakin (DSP), the primers were: 50-CAG-
TGGTGTCAGCGATGATGT-30 and 50-TGACGCTGGATA-
TGGTGGAA-30; for human connexin 26 (GJB2), the primers
were: 50-CTGGCTCACCGTCCTCTTCA-30 and 50-GCAGC-
CACAACGAGGATCA-30 and for human connexin 31
(GJB3), the primers were: 50-TCTGGCATGGCTTCAATA-
TGC-30 and 50-GGCAATGTAGCAGTCCACGAT-30. For
human TBP (TATA-box binding protein), the primers were
50-CGGCTGTTTAACTTCGCTTC-30 and 50-CACACGCC-
AAGAAACAGTGA-30 and the Taqman probe sequence
was: 50-FAM-CATAGTGATCTTTGCAGTGACCCAG-
CAGC-TAMRA-30; for human UBC (Ubiquitin C), the
primers were: 50-ATTTGGGTCGCGGTTCTTG-30 and 50-
TGCCTTGACATTCTCGATGGT-30 and for human GAPD
(Glyceraldehyde-3-phosphate dehydrogenase), the primers
were: 50-TGCACCACCAACTGCTTAGC-30 and 50-GGCAT-
GGACTGTGGTCATGAG-30. Primers for PCR analysis for
chromatin immunoprecipitation (ChIP) of a proximal frag-
ment of the human E-cadherin promoter (86 to +60)
were: 50-GGCCGGCAGGTGAAC-30 and 50-GGGCTGGAG-
TCTGAACTGAC-30; primer sequences for the human plako-
philin 2 proximal promoter (529 to 391) were: 50-GCGA-
CAAAGCCTGACTAACCA-30 and 50-GGATGGATTTCC-
GCTCGAT-30; primer sequences for the human tight junction
protein 3 proximal promoter (784 to 563) were: 50-CTG-
CAACTCAGGCGCTGTTC-30 and 50-CCTGAGTAGCTGG-
GCTCCTGAG-30 and primer sequences for the human
connexin 26 proximal promoter (1088 to 1017)
were: 50-CCCCCAGCAGGTGTG-30 and 50-AAGGGG-
GAAACTGATAGGAT-30. Primers for a distal region of
the E-cadherin promoter (4834 to 4779) were: 50-
TGCCAGGTGACAGGGTCTCT-30 and 50-AGAGGCCTT-
GCCCTTCAGAT-30; primers for a distal region of the plako-
philin 2 promoter (6039 to 5974) were: 50-GGCAGCTG-
TGGTCATCCAT-30 and 50-GGGCATGCAGAAGCACAGTAC-30
primers for a distal region of the tight junction protein 3 pro-
moter (4416 to 4337) were: 50-CCGTGAAACATGTCC-
CAGATT-30 and 50-ACCTCACAGCCCACCTCATC-30 and
primers for a distal region of the connexin 26 promoter (4294
to4232) were: 50-AAAAGCTACTGCCGTCCATCA-30 and
50-ACAAGGGCAATAGAGCGATGA-30.
Collagen invasion and fast aggregation assay
For the collagen invasion assay, cells were seeded on gelified
Collagen S (type I, 0.22%) solution (Seromed, Biochrom KG,
Berlin, Germany) and the invasion assay was performed as
described (26). For a fast cell aggregation assay, single cell
suspensions were prepared according to an E-cadherin protein
saving procedure (27). Cells were incubated in an isotonic
buffer containing 1.25 mM Ca2+ under continuous shaking.
E-cadherin was functionally blocked using DECMA-1
(Sigma; 1:500). Particle diameters were measured in a Coulter
particle size counter LS200 (Coulter, Electronics Ltd) at the
start (N0) and after 30 min of incubation (N30); these results
were plotted against the percentage of volume distribution
(expressed as percent of the total cell volume).
Isolation of promoter fragments and reporter assays
The human P-cadherin, claudin 4 and connexin 26 promoter
sequences were identified by screening the public human
genomic DNA database (http://genome.ucsc.edu) with the
respective cDNA fragments. These promoter sequences
were amplified by PCR from genomic DNA isolated from
MDA-MB-435S1 cells. Primers used for P-cadherin were:
50-ACGGGAGGTGGAGAAAGAG-30 and 50-AGAGAGAG-
GGGTGAAGCAG-30; for claudin 4: 50-GGGGTACCTTCT-
GGGGGACCTGTTCA-30 and 50-CCCAAGCTTCTTAACG-
TTCGCAGAGTG-30 and for connexin 26: 50-GGGGTACC-
GGGCGCCAATTTTTCAAG-30 and 50-CCCAAGCTTGGC-
CGCAACACCTGTCTC-30. Amplified fragments were
cloned in the pGL3basic vector (Promega, Madison, WI), in
which the multicloning site was exchanged for the promoter
fragments. The 1554 bp connexin 26 promoter, containing
5 SIP1-binding sites, was shortened to a 1294 bp fragment
by removing the most distal SIP1-binding element using KpnI
and NruI. Transient transfection with the luciferase reporter
constructs and cotransfection with the pCS3SIP1FS expres-
sion vector in MCF7/AZ cells was performed using FuGENE
6 reagent (Roche). Approximately 200 000 cells were seeded
per 10 cm2 well. After 24 h, 500 ng of each plasmid DNA
was transfected. Luciferase activity was measured with a
Galacto-Star kit (Tropix) 48 h after transfection. Transfection
was normalized by measuring b-galactosidase (Galacto-Star
kit; Tropix), encoded by the co-transfected pUT651 plasmid
(Eurogentec). Mutagenesis of the SIP1-binding sites in the
human connexin 26 promoter segment was performed
with the QuickChange Multi Site-Directed Mutagenesis Kit
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(Stratagene) using 4 primers, each mutated in the SIP1-binding
sequence: Mut 1: 50-AAGTGGGTGCCCGAGATGGGG-
CGGGGGTTG-30; Mut 2: 50-CCAGAAAGCCCCCAGCA-
GATGTGCAGTGCAGAGC-30; Mut 3: 50-CCTCACCCCG-
AAAGGAGTCATCTCCTTGCAGTTCC-30; Mut 4: 50-CC-
ACGGCGGGAGACAGATGTTGCGGCCAAGC-30.
ChIP assays
DLD1Tr21/WTSIP1 and A431/WTSIP1 cells were grown for
24 h up to 80% confluency in the absence or presence of Dox.
Cells were then crosslinked with 1% formaldehyde and pro-
cessed using the ChIP-IT kit from Active Motif as described
(28). Purified immunoprecipitated DNA was used for real-time
quantitative PCR.
RESULTS
Exogenous SIP1 expression induces morphological
changes in human epithelial cells
We reported previously that SIP1 induces downregulation of
endogenous E-cadherin in the MDCK cell line (7). One way to
further elucidate the functional role of SIP1 in dedifferenti-
ation and invasion of epithelial cells is to analyze SIP1-
mediated differential gene expression. The human
DLD1Tr21 cell line is an E-cadherin positive colon cancer
cell line expressing high levels of the tetracycline repressor
(TetR) protein. Using stable transfection with expression vec-
tors under control of the Tet responsive promoter for myc-
tagged wild-type and mutant SIP1, we created the inducible
model cell systems DLD1Tr21/WTSIP1 and DLD1Tr21/
mutSIP1, respectively. Furthermore, a similar Tet-on indu-
cible human epidermoid cancer cell line, A431/WTSIP1
was constructed (J. Mejlvang et al., manuscript submitted).
Addition of Dox to the cell cultures resulted in a dose-
dependent expression of SIP1. Nuclear expression of SIP1
was detectable by immunofluorescence after 4 h of Dox treat-
ment. The cells expressing SIP1 underwent a dramatic
morphological conversion, from an epithelial cell state to a
fibroblast-like phenotype, which was most apparent after
4 days of SIP1 expression (Figure 1). This conversion was
not due to changes in the expression status of the other
E-cadherin repressing transcription factors Snail or Slug, as
they showed no detectable mRNA expression in the
DLD1Tr21 cell line conditionally expressing SIP1 (data not
shown). The status of the E-cadherin–catenin complex was
studied in detail by immunofluorescence and western blot
analysis (Figure 2). Expression of SIP1 resulted in the loss
of membranous E-cadherin and aE-catenin expression and in
their internalization. Western blot analysis revealed that pro-
tein levels of E-cadherin and aE-catenin were significantly
decreased only after 4 days of SIP1 expression. However, Q-
RT–PCR experiments showed that extensive repression of
endogenous E-cadherin mRNA was already evident after 12
h of SIP1 protein expression (Figure 3). On the other hand, the
aE-catenin mRNA levels remained unchanged after SIP1
expression (data not shown). b-catenin protein was relocal-
ized, but unlike aE-catenin, it was not strongly downregu-
lated. It should be noted that APC is mutated in the
DLD1Tr21 cell line, and so b-catenin cannot be degraded
by the ubiquitin-proteasome machinery in the DLD1Tr21
derivatives. b-catenin was translocated to the cytoplasm and
putatively also to the nucleus, even though nuclear b-catenin
staining was barely detected (Figure 2A). The SIP1-induced
changes in p120ctn protein levels are also remarkable.
Immunofluorescence analysis indicated that expression of
p120ctn decreased at the cell contacts (Figure 2A). Due to
alternative splicing of internal exons and multiple translation
initiation sites, several p120ctn isoforms can be expressed
from a single gene (29,30). For the induced SIP1-
expressing DLD1Tr21/WTSIP1 cell line, western blot analysis
revealed an upregulation of a protein of 120 kDa, represent-
ing p120ctn isoform 1 (Figure 2B). On the other hand, isoform
3 was clearly downregulated upon SIP1 expression. This
inverse regulation of p120ctn isoforms by SIP1 was also detec-
ted in A431/WTSIP1 (data not shown).
Wild-type SIP1 induces loss of aggregation and invasion
but mutant SIP1 does not
The adhesion function of the E-cadherin–catenin complex is
lost in the induced SIP1-expressing cells. In a fast aggregation
assay, induced DLD1Tr21/WTSIP1 cells showed loss of
cell–cell aggregation, whereas expression of the mutant
Figure 1. The stable transfectants DLD1Tr21/WTSIP1 and A431/WTSIP1 expressing SIP1. (A) Phase contrast images demonstrate the morphological changes
that follow induction of SIP1 in vitro. The non-induced DLD1Tr21/WTSIP1 and A431/WTSIP1 cell lines display a general epithelial phenotype. WTSIP1 induces
a clear morphological change in these cells whereas mutant SIP1 does not. (B) Immunofluorescence analysis with a monoclonal antibody directed against the myc-tag
confirmed the absence of SIP1 protein from the non-induced cell lines and its presence in the induced cell lines.
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Figure 2. Behavior of the different proteins of the cadherin–catenin complex upon SIP1 induction. (A) Immunofluorescence microscopy of non-induced and induced
DLD1Tr21/WTSIP1 cells using antibodies specific for adherens junction components. E-cadherin as well as aE-catenin, p120ctn and b-catenin became nearly
undetectable at cell–cell contacts in the SIP1-induced cells. (B) Western blot analysis of the non-induced and induced DLD1Tr21/WTSIP1 cell line. E-cadherin
and aE-catenin were downregulated at the protein level in the SIP1-expressing cells. b-catenin protein levels were unaltered in the SIP1-induced compared to
non-induced cells. Protein expression of p120ctn isoform 1 was upregulated and that of isoform 3 downregulated after SIP1 induction (*: addition of Dox every 2 days,
**: washing away Dox from the cell culture medium).
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SIP1 had no effect on the aggregation capacity compared to
the non-induced cells (Figure 4A). SIP1 expression in
DLD1Tr21/WTSIP1 results in the induction of an invasive
phenotype (Figure 4B). Invasion into collagen type I was
induced as efficiently by SIP1 as by the E-cadherin-
blocking antibody DECMA-1 (data not shown). This is in
line with the demonstrated invasive behavior of MDCK
cells upon SIP1 expression (7). In contrast, the induction of
SIP1 protein, mutated in the zinc finger domains, in
DLD1Tr21/mutSIP1 cells had no influence on the in vitro
invasive behavior of these cells (Figure 4B). These data indic-
ate that functional DNA-binding of the SIP1 protein is needed
to convert the cells to a more mesenchymal phenotype.
Wild-type SIP1 downregulates expression of tight
junction, adherens junction, desmosome and gap
junction proteins at the mRNA level
In order to gain better insight into the functional impact of
SIP1 expression in epithelial cells, a comparative differential
gene expression analysis using cDNA microarrays was per-
formed (will be reported elsewhere) 12, 24 and 48 h after SIP1
induction. Besides E-cadherin, a distinct but large set of genes
encoding proteins localized in the different epithelial cell junc-
tions showed modified expression. The differential expression
of transcripts encoding tight junction, adherens junction, des-
mosome and gap junction proteins was confirmed by Q-RT–
PCR in the DLD1Tr21/WTSIP1 versus DLD1Tr21/mutSIP1
cell line (Figure 5). SIP1-mediated downregulation was shown
for transcripts encoding E-cadherin, P-cadherin, claudin 4,
tight junction protein 3 (ZO-3), plakophilin 2, desmoplakin,
connexin 26 (GJB2) and connexin 31 (GJB3). None of the
genes that were downregulated by wild-type SIP1 were
repressed by mutant SIP1. To further verify the authenticity
of the observations made on the transcript level, we performed
immunofluorescence analysis for proteins encoded by
SIP1-repressed genes from both the non-induced and SIP1-
induced DLD1Tr21/WTSIP1 and A431/WTSIP1 cell lines.
The desmosomal proteins desmoplakin and plakophilin 2
Figure 3. Downregulation of E-cadherin mRNA due to induction of SIP1 expression in DLD1Tr21/WTSIP1 cells. Q-RT–PCR for mRNA expression of SIP1 and
E-cadherin. E-cadherin downregulation is already clear after 12 h of SIP1 induction. Maximum inhibition was observed after 24 h of induction. TBP amplification
was used to normalize the values.
Figure 4. Wild-type SIP1 induces loss of cell aggregation and invasion whereas mutant SIP1 does not. (A) Fast aggregation assay. No cell aggregates were detected in
liquid cell suspensions at time 0 (N0). After 30 min, cell–cell aggregation was detected for the DLD1Tr21 cell line expressing mutant SIP1, but no aggregates were
detected when the cell line expressed wild-type SIP1. (B) Invasion into type I collagen was induced by induction (+Dox) of expression of wild-type SIP1 but it was not
induced by mutant SIP1.
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were clearly downregulated (Figure 6). The tight junction
protein claudin 4 was also repressed at the protein level by
induction of SIP1.
SIP1 induces cadherin switching in A431/WTSIP1 cells
In contrast to E-cadherin, N-cadherin is believed to promote
cell migration and tumor progression, and has been shown
previously to be upregulated in invasive cancer cell lines
(31,32). Q-RT–PCR revealed upregulation of N-cadherin
mRNA in A431/WTSIP1 cells 48 h after induction of SIP1,
while E-cadherin expression was strongly downregulated
(Figure 7A). This cadherin switching was confirmed at the
protein level (Figure 7B).
Effect of SIP1 expression on promoter activities
After induction of SIP1, morphological changes were
observed only in the DLD1Tr21/WTSIP1 cell line, not in
the DLD1Tr21/mutSIP1, in which SIP1 is mutated in both
zinc finger clusters and is therefore unable to bind promoter
sequences (2,7). Indeed Q-RT–PCR analysis revealed that the
SIP1 regulated genes in the SIP1-induced cell line were
repressed only by the wild-type SIP1, not by the mutated
SIP1 protein. This indicates that the SIP1-induced morpholo-
gical changes observed are caused by direct functional pro-
moter regulation of target genes. Until now, E-cadherin is the
only known target gene of SIP1 which is known to be involved
in EMT and invasion processes (7). Therefore, we investigated
whether the promoters of several putative SIP1 target genes
are directly regulated by SIP1. Initially, the promoters of
P-cadherin, claudin 4 and connexin 26 (GJB2) were screened
for the presence of SIP1-binding sites [CACCT(G)], and suit-
able fragments were cloned in the pGL3basic vector upstream
of the luciferase reporter gene. In the P-cadherin promoter
(531 bp) 1 AGGTG and 3 CACCTG sequences are present.
One CACCT and two AGGTG sequences were identified in
the claudin 4 promoter (635 bp) (Figure 8A). Finally, the
isolated connexin 26 promoter fragment that was cloned
(1294 bp) contains 1 CACCT, 1 AGGTG and 2 CAGGTG
sequences. To elucidate whether SIP1-binding affects the
transcriptional activity of these cloned promoters, we transi-
ently co-transfected the reporter plasmids together with a SIP1
expression vector in the E-cadherin positive epithelial cell line
Figure 5. SIP1 downregulates the mRNA expression levels of constituents of tight, adherens, desmosomal and gap junctions in epithelial cells. Total RNA was
isolated from DLD1Tr21/WTSIP1 and DLD1Tr21/mutSIP1 cell lines after induction with Dox (at 12 h, 24 h and 48 h) or without Dox. Q-RT–PCR analysis for the
genes indicated was compared with the microarray results. It is clear that all these transcripts are downregulated by WTSIP1, but the expression of none of them was
affected in the cell line expressing mutant SIP1. Amplification of TBP, UBC and GAPD was used to normalize the values.
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MCF7/AZ. SIP1 expression caused significant decreases in the
promoter activities of P-cadherin, claudin 4 and connexin 26
(Figure 8C). To address the specificity of SIP1 action, the 4
SIP1-binding sites present in the human connexin 26 promoter
were mutated, either separately or in different combinations
(Figure 8B). When these mutant connexin 26 promoter
constructs were co-transfected with SIP1 cDNA, the SIP1
repressive activity was diminished (derepressed) only when
all 4 SIP1-binding sites were mutated (Figure 8C). Mutating 1,
2 or 3 SIP1 recognition sequences did not have a large impact
on the repressed promoter activity. These data show that the
integrity of a single SIP1-binding element in the connexin 26
promoter is sufficient for recruitment of SIP1 to the promoter
and significant repressive activity. These findings are in line
Figure 6. SIP1 downregulates different proteins of the tight junctions and desmosomes. Immunofluorescence microscopy of non-induced and induced DLD1Tr21/
WTSIP1 and A431/WTSIP1 cells using specific antibodies for tight junctional and desmosomal components. SIP1 expression decreases expression of desmoplakin
and PKP2 at contact regions. Claudin 4 expression at the tight junctions was affected by SIP1 expression. DAPI staining was done in DLD1Tr21/WTSIP1 and
PI (propidium iodide) staining in A431/WTSIP1 to visualize nuclei of the same cell fields.
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with the results obtained previously with the E-cadherin pro-
moter in which both SIP1-binding sites had to be
mutated in order for SIP1 to lose its repressive activity
(Figure 8C) (7).
SIP1 associates at the chromatin level with promoters
containing SIP1-binding sites
We wanted to investigate whether SIP1 associates directly, at
the chromatin level, with these new target genes via their SIP1-
binding sites. Therefore, we performed chromatin immuno-
precipitation (ChIP) assays in both the DLD1Tr21/WTSIP1
and the A431/WTSIP1 inducible cell systems. Cells were
grown to 80% confluency in the absence or presence of
Dox. After 24 h the cells were crosslinked with 1% formal-
dehyde and harvested. A SIP1-specific mouse monoclonal
antibody was used to pull down any chromatin fragment phys-
ically bound by SIP1. Background was determined using an
irrelevant IgG antibody. Quantitative PCR performed with
primers specific for SIP1-binding site containing promoter
fragments of E-cadherin (CDH1), plakophilin 2 (PKP2),
tight junction protein 3 (ZO-3) and connexin 26 (CX26)
revealed an enrichment of these sequences after induction
of SIP1 (Figure 9), whereas distal promoter sequences for
these genes showed no significant enrichment. This indicates
that SIP1 can directly downregulate expression of epithelial
cell junctional genes in a direct manner by physically inter-
acting with the promoter regions containing SIP1-binding
sites.
DISCUSSION
EMT occurs frequently during normal development in pro-
cesses such as mesoderm and neural crest cell formation.
During tumor progression, EMT is also crucial for loss of
cell polarity of epithelial cells, thus facilitating migratory
and invasive behavior. The involvement of the transcription
factor SIP1/ZEB2 during EMT in developmental processes
was indicated by the phenotype of the SIP1 knock-out
mouse (17). Loss of SIP1 expression was correlated with
loss of the migratory capacities of neural crest cells. Retroviral
insertion mutagenesis suggested that SIP1 could contribute to
oncogenic transformation (9). Furthermore, the upregulation
of ZEB-family members during EMT was recently demon-
strated (33). To study the role of SIP1 in more detail in EMT-
like processes, we generated human cell lines with conditional
SIP1 expression. In these Tet-on cell systems, adding Dox to
the cell culture medium resulted in nuclear expression of SIP1.
A drastic morphological change was induced in these epithe-
lial cells as a consequence of exogenous SIP1 expression. As
the transmembrane cell adhesion protein E-cadherin is a direct
target of SIP1, we analyzed the expression of the different
components of the cadherin–catenin complex. Downregula-
tion of protein and mRNA levels was only detected for
E-cadherin. The complexing aE-catenin was altered only at
the protein expression level, probably as a consequence of loss
of E-cadherin expression (34). Different p120ctn isoforms
were inversely regulated during the SIP1-induced EMT-like
process. The upregulation of p120ctn isoform 1 (120 kDa)
Figure 7. Cadherin switching in A431/WTSIP1 upon SIP1 induction. (A) Q-RT–PCR for E-cadherin and N-cadherin mRNAs in A431/WTSIP1. E-cadherin was
clearly downregulated after 48 h of SIP1 induction, while N-cadherin mRNA was upregulated. TBP and GAPD amplification was used to normalize the values.
(B) Western blot analysis showed a similar inverse correlation between E-cadherin and N-cadherin protein levels after induction of SIP1.
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and the downregulation of isoform 3 (100 kDa) indicate
putative specific roles for different isoforms in epithelial
and mesenchymal states. A similar shift in p120ctn isoform
expression was seen in FosER cells, in which EMT is induced
as a consequence of FosER activation by estradiol addition
(35). This shift is in line with the previously observed pre-
dominant expression of 100 kDa and 120 kDa isoforms in
epithelial cells and in highly motile fibroblastoid cells, respect-
ively (36). The functional difference between these isoforms
remains to be elucidated. The other E-cadherin-binding Arma-
dillo protein b-catenin showed no decrease in mRNA and
protein expression levels, but b-catenin was no longer
expressed at the cell–cell contacts. SIP1 expression resulted
in the redistribution of b-catenin to the cytoplasm and possibly
also to the nucleus.
The E-cadherin promoter was previously identified as a
direct target of SIP1. SIP1 binds to the E2-boxes (CACCTG)
present in the E-cadherin promoter, resulting in downregula-
tion of the promotor’s activity (7). Global gene expression
analysis using the in vitro SIP1-induced cell models revealed
that SIP1 expression results in downregulation of major con-
stituents of different cell junctional complexes, such as tight
junctions, adherens junctions, desmosomes and gap junctions.
Interestingly we found by Q-RT–PCR analyis that SIP1 down-
regulates several cell junction genes on the transcript level.
The fact that expression of a SIP1 mutant, with one missense
mutation in each of the zinc finger clusters, has no effect on
mRNA expression levels of these regulated genes, suggests
that downregulation by SIP1 is mediated mainly via promoter
regulation. Both zinc finger clusters are indeed needed for
Figure 8. SIP1 transcriptionally downregulates genes of several intercellular junctional complexes. (A) Schematic overview of the cloned promoter regions of
E-cadherin, P-cadherin, claudin 4 and connexin 26. The putative SIP1-binding sites are indicated. (B) Mutations generated in the SIP1-binding sites of the human
E-cadherin promoter (7) and the human connexin 26 promoter. E2-boxes are shaded gray. Mut 4 carries the mutation CAGGTG! CAGATG; Mut 2 + 4 carries 2
identical CAGGTG!CAGATG mutations; Mut 1 + 2 + 4 carries an additional AGGTG!AGATG mutation; Mut 1 + 2 + 3 + 4 carries the 3 mutations described
above and has a CACCT ! CATCT mutation in SIP1-binding site 3. (C) Promoter activity assays on extracts of transfected MCF7/AZ cells. Cells were co-
transfected with a SIP1 expression vector and luciferase promoter constructs for E-cadherin, P-cadherin, claudin 4 or connexin 26. Co-expression of SIP1 with the
promoter constructs resulted in downregulation of promoter activities. Mutation of all 4 SIP1-binding elements in the connexin 26 promoter (see B) relieved the
repressive activity of SIP1. Mutation of less than 4 SIP1-binding sequences preserved the repressive effect of SIP1. Luciferase values are normalized with
b-galactosidase activities.
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SIP1-dependent promoter repression via E-box-binding (7).
Cloning of the promoter regions of the regulated genes con-
nexin 26 (in the gap junctions), P-cadherin (at the adherens
junction) and claudin 4 (in the tight junctions) revealed the
presence of several SIP1-binding sequences in each of them.
Mutation of these elements in the cloned connexin 26 pro-
moter showed the importance of the integrity of these
sequences in the SIP1-dependent suppressive activity. Further-
more, we could demonstrate physical interaction at the
chromatin level between SIP1 and the promoter regions of
E-cadherin, plakophilin 2, connexin 26 and ZO-3, all of
which contain SIP1-binding sites.
The change in expression and distribution of those SIP1
target genes during EMT could be explained as a secondary
consequence of repression of E-cadherin. A crucial role for
E-cadherin in epithelial cell polarity has been well docu-
mented (37–39). However, exogenous E-cadherin expression
in mesenchymal cells expressing EMT inducers such as Snail
cannot restore the epithelial phenotype (19,40,41). Moreover,
downregulation of the tight junction components, occludins
and claudins, by Snail was linked to repression of their pro-
moter activity (18,19). Hence, we have to conclude that
E-cadherin and other junctional genes are simultaneously
downregulated as part of the SIP1 driven reprogramming dur-
ing EMT. It remains enigmatic though why these different
junctional genes are repressed in a coordinated fashion. We
do know that some of these genes can be regarded as NACos,
proteins that can localize both to the nucleus and adhesion
complexes (42). Such proteins have the intriguing potential to
coordinate the regulation of cell adhesion and transcription.
The function of several NACos proteins belonging to the
Armadillo family such as PKP2, b-catenin and p120ctn
seem to be affected in epithelial cells with SIP1 expression.
The desmosomal PKP2 has been reported to be present also in
Figure 9. SIP1 associates with the promoter regions of cell junction genes at the chromatin level. (A) Promoter regions of junctional genes repressed by SIP1. The
promoter region, 50 untranslated region (50-UTR), open reading frame (ORF) and intron were defined using the sequence information derived from the Database for
Transcriptional Start Sites (http://dbtss.hgc.jp) and the public human genomic DNA database (http://genome.ucsc.edu) using the Refseq Ids as mentioned under the
gene symbol. CACCT(G) and (C)AGGTG boxes were mapped. Amplicons analyzed in the chromatin immunoprecipitation are shown as black bars. (B) DLD1Tr21/
WTSIP1 and A431/WTSIP1 cells were either not induced or induced with Dox for 24 h. In vivo binding of SIP1 to proximal promoter sequences in DLDTr21/
WTSIP1 and A431/WTSIP1 cells, as determined by ChIP analysis. Enrichment of bound sequences was quantified by quantitative real-time PCR and is depicted as
the fold increase of association of SIP1 detected with a SIP1-specific antibody in the Dox induced cells versus non-induced cells. Background was determined using
an irrelevant IgG antibody and is also depicted as the fold increase in the induced versus non-induced cells. Irrelevant sequences (Irr. seq.) are amplified distal
promoter sequences, 4 to 7 kb upstream of the transcription start site of E-cadherin, plakophilin 2, tight junction protein 3 and connexin 26.
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the nucleus at all times. This protein seems to be part of
particles containing RNA polymerases (43). Moreover the
transcription factor Snail is also able to repress PKP2 expres-
sion very potently (19). This strong downregulation of PKP2
suggests that inhibiting the potential role of PKP2 in adhesion
and/or transcriptional regulation could be essential in the
process of EMT. It is at present not clear if the SIP1-induced
isoform switching has functional consequences for a particular
nuclear role of p120ctn (23). P120ctn can interact with Kaiso
and has as such the potential to influence beta-catenin/
TCF signaling (44). On the other hand, downregulation of
E-cadherin could result in loss of b-catenin sequestration to
sites of cell–cell adhesion, enabling b-catenin/TCF mediated
transcription. However SIP1 did not induce clear nuclear
b-catenin localization nor enhanced WNT signaling (data
not shown).
Enhanced SIP1 expression has so far been reported in a
distinct set of cancers comprising gastric, hepatocellular, ovar-
ian and breast carcinomas (8,45,46). Here, the described
candidate SIP1 target genes have been documented to show
abberant expression in a variety of human cancer types
(47–50). This suggests that repression of these genes could
be due to enhanced SIP1 expression, although this has to be
examined in detail in the near future.
Taken together, the present results identify the SIP1 protein
as an important mediator of epithelial dedifferentiation
through direct downregulation of a distinct set of constituents
of adherens junctions, tight junctions, desmosomes and gap
junctions, which are key determinants of the epithelial pheno-
type, including epithelial cell polarity.
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